Olinger Margaret (CIK 0001898725)

Latest company ownership

Role: Chief Commercial Officer
Shares held
25,000
Last filed at
Dec 29, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 6, 2023 Jan 10, 2023 Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Buy 72.5 +2,403 0.56% $87.2K
Jan 6, 2022 Jan 10, 2022 Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Buy 95.0 +35,175 19.37% $130K